drugset / Trial / NCT05111769

Preliminary Study on the Clinical Effect of Recombinant Human Brain Natriuretic Peptide on Sepsis Complicated With Heart Failure

NCT05111769 ↗

Unknown 70 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The investigators intend to conduct clinical studies to determine the efficacy of rhBNP in the treatment of septic related dysfunction and kidney dysfunction

Timeline

Start
2021-12-01
Primary completion
2023-12-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject recombinant human brain natriuretic peptide Peptide — —